Filing Flows › Comparisons › PFHO vs MGRX
Pacific Health Care Organization vs Mangoceuticals: PFHO and MGRX compared
Pacific Health Care Organization is the larger company: $1.5M of revenue in its latest quarter (Q3 2026) against $69K for Mangoceuticals (Q2 2026). Pacific Health Care Organization is growing faster (-5% against -59% a year earlier).
Where the money goes: PFHO and MGRX
Pacific Health Care Organization (PFHO) · Q3 2026
Pacific Health Care Organization, Q3 2026: revenue $1.5M (-5% year over year), operating margin 8.9%, net earnings $335K, operating cash flow $507K. The chart follows the revenue to costs, profit and cash.
Mangoceuticals (MGRX) · Q2 2026
Mangoceuticals, Q2 2026: revenue $69K (-59% year over year), net loss $1.3M, operating cash flow −$261K. The chart follows the revenue to costs, profit and cash.
| Pacific Health Care Organization (PFHO) | Mangoceuticals (MGRX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $1.5M | $69K |
| Revenue growth, Y/Y | -5% | -59% |
| Operating margin | 8.9% | n/m |
| Net earnings | $335K | −$1.3M |
| Net margin | 22.1% | — |
| Operating cash flow | $507K | −$261K |
| Free cash flow | $507K | — |
Where the revenue comes from
Pacific Health Care Organization
- Utilization Review: $643K (43%)
- Medical Case Management: $476K (31%)
- HCO: $190K (13%)
- MPN: $106K (7%)
Questions
Which is bigger, Pacific Health Care Organization or Mangoceuticals?
Pacific Health Care Organization is the larger company: $1.5M of revenue in its latest quarter (Q3 2026) against $69K for Mangoceuticals (Q2 2026).
Is Pacific Health Care Organization or Mangoceuticals growing faster?
Pacific Health Care Organization is growing faster (-5% against -59% a year earlier).
More: Pacific Health Care Organization earnings · how Pacific Health Care Organization makes money · Mangoceuticals earnings · how Mangoceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.